Chartwell Investment Partners LLC reduced its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 9.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 341,779 shares of the company's stock after selling 34,001 shares during the quarter. Chartwell Investment Partners LLC owned 0.18% of ChampionX worth $10,305,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC acquired a new position in shares of ChampionX during the first quarter worth about $27,000. Blue Trust Inc. raised its stake in shares of ChampionX by 442.4% in the 3rd quarter. Blue Trust Inc. now owns 1,329 shares of the company's stock worth $44,000 after buying an additional 1,084 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in ChampionX in the 2nd quarter valued at about $68,000. UMB Bank n.a. boosted its holdings in ChampionX by 63.7% during the third quarter. UMB Bank n.a. now owns 2,266 shares of the company's stock worth $68,000 after buying an additional 882 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC acquired a new stake in shares of ChampionX during the second quarter worth $194,000. 98.99% of the stock is owned by hedge funds and other institutional investors.
ChampionX Price Performance
NASDAQ CHX traded up $0.66 on Monday, hitting $31.45. 1,014,282 shares of the company's stock were exchanged, compared to its average volume of 1,865,914. ChampionX Co. has a 52 week low of $25.46 and a 52 week high of $39.95. The company has a current ratio of 1.94, a quick ratio of 1.20 and a debt-to-equity ratio of 0.33. The stock has a market cap of $5.99 billion, a price-to-earnings ratio of 19.12 and a beta of 2.38. The stock has a 50-day moving average of $30.07 and a 200-day moving average of $31.76.
ChampionX (NASDAQ:CHX - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.01). ChampionX had a return on equity of 19.74% and a net margin of 8.59%. The firm had revenue of $906.53 million during the quarter, compared to analysts' expectations of $916.50 million. During the same period last year, the business posted $0.41 EPS. The company's revenue was down 3.5% compared to the same quarter last year. Analysts expect that ChampionX Co. will post 1.66 earnings per share for the current year.
ChampionX Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, October 4th were paid a $0.095 dividend. This represents a $0.38 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date of this dividend was Friday, October 4th. ChampionX's payout ratio is 23.60%.
Analyst Upgrades and Downgrades
Separately, Piper Sandler decreased their price target on shares of ChampionX from $40.00 to $33.00 and set a "neutral" rating for the company in a report on Monday, July 15th.
Get Our Latest Stock Report on ChampionX
Insider Activity
In related news, insider Deric D. Bryant sold 49,303 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $30.06, for a total transaction of $1,482,048.18. Following the completion of the sale, the insider now directly owns 337,409 shares in the company, valued at approximately $10,142,514.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.38% of the company's stock.
ChampionX Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Further Reading
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.